| Literature DB >> 34980014 |
Songjiao Zhao1, Qihua Le2,3,4.
Abstract
BACKGROUND: Tear film instability plays an important role in the course of Sjögren's Syndrome dry eye (SSDE) even though it is generally classified as aqueous-deficient dry eye. The measurement of the first tear film break-up point (FTBUP) helps to evaluate the most unstable position of the tear film on ocular surface. We aim to investigate FTBUP in Sjögren's Syndrome dry eye (SSDE) and non-Sjögren's Syndrome dry eye (NSSDE) patients, and explore its correlation with dry eye indices.Entities:
Keywords: Non-Sjögren’s syndrome dry eye; Sjögren’s syndrome dry eye; The first tear film break-up point
Mesh:
Substances:
Year: 2022 PMID: 34980014 PMCID: PMC8722312 DOI: 10.1186/s12886-021-02233-6
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Fig. 1(A) Representative output images of the noninvasive tear film break-up points and tear break-up time measurement from a non-Sjögren’s Syndrome Dry Eye (a) and a Sjögren’s Syndrome Dry Eye (b). The colored tear map showed the position of tear break-up point and the break-up time. Red: 0–6 s; orange/yellow: 6–12 s; green: 12–24 s. (B) Representative output images of meibography from a non-Sjögren’s Syndrome Dry Eye (a) and a Sjögren’s Syndrome Dry Eye (b). The meibomian gland dropout was more severe in Sjögren’s Syndrome Dry Eye (b) than non-Sjögren’s Syndrome Dry Eye (a). (C) The cornea surface was divided into five areas when observing cornea fluorescein staining
Comparison of FTBUP between SSDE and NSSDE, and between eyes with and without fluorescein staining (n = eyes)
| Supranasal | Supratemporal | Inferonasal | Inferotemporal | Total | ||||
|---|---|---|---|---|---|---|---|---|
| SSDE | FL (−) | 4 (26.7%) | 0 (0.0%) | 5 (33.3%)) | 6 (40.0%) | 15 (100.0%) | .338 | |
| FL (+) | 0 (0.0%) | 2 (6.9%) | 12 (41.4%)) | 15 (51.7%) | 29 (100.0%) | |||
| Total | 4 (9.1%) | 2 (4.5%) | 17 (38.6%)) | 21 (47.7%) | 44 (100.0%) | |||
| NSSDE | FL (−) | 7 (18.4%) | 6 (15.8%) | 14 (36.8%) | 11 (28.9%) | 38 (100.0%) | .215 | |
| FL (+) | 1 (16.7%) | 0 (0.0%) | 3 (50.0%) | 2 (33.3%) | 6 (100.0%) | |||
| Total | 8 (18.2%) | 6 (13.6%) | 17 (38.6%) | 13 (29.5%) | 44 (100.0%) | |||
| Total | 20 (22.7%) | 68 (77.3%) | ||||||
| FL (−) | SSDE | 4 (26.7%) | 0 (0.0%) | 5 (33.3%)) | 6 (40.0%) | 15 (100.0%) | .865 | |
| NSSDE | 7 (18.4%) | 6 (15.8%) | 14 (36.8%) | 11 (28.9%) | 38 (100.0%) | |||
| Total | 11 (20.8%) | 6 (11.3%) | 19 (35.8%) | 17 (32.1%) | 53 (100.0%) | |||
| FL (+) | SSDE | 0 (0.0%) | 2 (6.9%) | 12 (41.4%)) | 15 (51.7%) | 29 (100.0%) | .688 | |
| NSSDE | 1 (16.7%) | 0 (0.0%) | 3 (50.0%) | 2 (33.3%) | 6 (100.0%) | |||
| Total | 1 (2.9%) | 2 (5.7%) | 15 (42.9%) | 17 (48.6%) | 35 (100.0%) | |||
| Total | 20 (22.7%) | 68 (77.3%) | ||||||
SSDE Sjögren’s Syndrome Dry Eye, NSSDE Non- Sjögren’s Syndrome Dry Eye
FL(+), the presence of fluorescein staining; FL(−), the absence of fluorescein staining
*∆: Generalized estimating equation between SSDE and NSSDE groups in four different quadrants
*‡: Generalized estimating equation between SSDE and NSSDE groups in superior and inferior quadrants
**∆: Generalized estimating equation between FL (−) and FL (+). patients in four different quadrants
**‡: Generalized estimating equation between FL (−) and FL (+). patients in superior and inferior quadrants
a: Generalized estimating equation between FL (−) and FL (+) in SSDE and NSSDE groups respectively
b: Generalized estimating equation between SSDE and NSSDE groups in FL (−) and FL (+) patients respectively
c: Generalized estimating equation between superior quadrants and inferior quadrants in SSDE and NSSDE groups respectively
d: Generalized estimating equation between superior quadrants and inferior quadrants in FL (−) and FL (+) patients respectively
e: Generalized estimating equation between superior quadrants and inferior quadrants
Demographic Data and Clinical Characteristics of SSDE and NSSDE
| NSSDE( | SSDE(n = 44) | ||
|---|---|---|---|
| Age | 53.41 ± 11.78 | 58.32 ± 12.11 | .057 |
| Sex | 3 M/19F | 2 M/20F | .644 |
| OSDI score | 13.45 ± 6.54 | 27.31 ± 7.80 | |
| Schirmer I test(mm/5 min) | 9.32 ± 7.75 | 3.57 ± 4.35 | |
| TMH(mm) | .19 ± 0.08 | 0.13 ± 0.08 | |
| FBUT(s) | 3.43 ± 1.74 | 1.70 ± 1.80 | |
| f-NIKBUT(s) | 5.60 ± 3.78 | 4.15 ± 2.26 | |
| Av-NIKBUT(s) | 7.98 ± 4.60 | 6.36 ± 4.32 | .193 |
| FL score | 0.16 ± 0.57 | 3.61 ± 4.46 | |
| Meibomian gland dropout rate(%) | |||
| Upper eyelid | 34.63 ± 13.47 | 47.52 ± 19.49 | |
| Lower eyelid | 49.57 ± 23.49 | 69.24 ± 20.69 | |
TMH Tear meniscus height, FBUT Fluorescein break-up time, f-NIKBUT First-noninvasive keratograph tear film break-up time, Av-NIKBUT Average-noninvasive keratograph tear film break-up time, FL score Fluorescein staining score
Generalized estimating equation was used to adjusted the correlation between right and left eyes
The distribution of meibomian gland dropout in SSDE and NNSDE
| Position of eyelid | NSSDE(%) | SSDE(%) | ||
|---|---|---|---|---|
| MG dropout of upper eyelid | Nasal part | 6 (13.6%) | 10 (22.7%) | .715 |
| Central part | 4 (9.1%) | 4 (9.1%) | ||
| Temporal part | 27 (61.4%) | 18 (40.9%) | ||
| Undifferentiated | 7 (15.9%) | 12 (27.3%) | ||
| MG dropout of lower eyelid | Nasal part | 13 (29.5%) | 13 (29.5%) | .591 |
| Central part | 0 (0%) | 1 (2.3%) | ||
| Temporal part | 7 (15.9%) | 2 (4.5%) | ||
| Undifferentiated | 24 (54.6%) | 28 (63.7%) | ||
| P value** |
MG Meibomian gland
*: Generalized estimating equation of MG dropout between SSDE and NSSDE groups in upper and lower eyelid
**: Generalized estimating equation of MG dropout between upper eyelid and lower eyelid in NSSDE and SSDE groups
Fig. 2The correlation analysis on dry eye examinations. A Meibomian gland dropout of upper eyelid had negative correlation with fluorescein break-up time and average noninvasive keratograph tear film break-up time (R = -.227, P = .033; R = -.268, P = .012), but no correlation with first noninvasive keratograph tear film break-up time (R = -.020, P = .854). B In Sjögren’s Syndrome Dry Eye patients, OSDI had a negative correlation with fluorescein break-up time (R = -.749, P<.001) but no correlation with both first noninvasive keratograph tear film break-up time and average noninvasive keratograph tear film break-up time (R = -.029, P = .851 and R = -.060, P = .700). C In non-Sjögren’s Syndrome Dry Eye patients, OSDI had a negative correlation with fluorescein tear film break-up time and average noninvasive keratograph tear film break-up time (R = -.705, P<.001; R = -.531, P<.001), but no correlation with first noninvasive keratograph tear film break-up time (R = -.128, P = .408)